← Leaderboards
Mark A Riddle
Johns Hopkins University
$6,095,923
Attributed
$6,528,496
Total exposure
11
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.3M · FY2005–18$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
Funding mix
By agency
NIH$6,528,496 · 11
By mechanism
R01$2,732,981 · 2
U01$1,999,465 · 2
T32$1,463,344 · 1
N01$330,391 · 1
M01$2,315 · 5
Top collaborators
- Golda Susan Ginsburg3 shared
Most similar at Johns Hopkins University
Same institution · by research overlap
- Philip J Leaf$30,810,671
- Lauren Parker$644,724
- John T. Walkup$13,819,292
- Melvin G McInnis$5,918,015
- Xiaobin Wang$26,054,340
Others in their field
Top investigators on “Clinical Research”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,040,569,537
- Leonard Freedman · Leidos Biomedical Research, Inc.$975,089,882
- Lawrence Corey · Fred Hutchinson Cancer Center$739,766,552
- Sonia M Thomas · Research Triangle Institute$700,865,642
- Jeffrey P Krischer · University Of South Florida$611,867,176
- Barton F Haynes · Duke University$538,862,577
Research focus
Clinical ResearchHuman SubjectChildHuman Therapy EvaluationResponseMental Disorder ChemotherapyClinical Trial Phase IPharmaceutical PreparationsSymptomsRandomizedSiteNational Institute Of Mental Health (U.S.)Adolescence (12-20)Child (0-11)Pediatric PharmacologyEffectivenessAdultYouthMethylphenidateMental DisordersAdverse EffectsDiagnosticCommunitiesDesign
Grant awards (40)
Child Anxiety Prevention Study Long term Extension$339,368
R01 · FY2018 · MH · contact PI
Child Anxiety Prevention Study Long term Extension$258,010
R01 · FY2017 · MH · contact PI
Child Anxiety Prevention Study Long term Extension$267,768
R01 · FY2016 · MH · contact PI
1/3-Improving Metabolic Parameters of Antipsychotic Child Treatment (IMPACT)$301,522
R01 · FY2012 · MH · contact PI
1/3-Improving Metabolic Parameters of Antipsychotic Child Treatment (IMPACT)$364,428
R01 · FY2011 · MH · contact PI
1/3-Improving Metabolic Parameters of Antipsychotic Child Treatment (IMPACT)$274,169
R01 · FY2010 · MH · contact PI
1/3-Improving Metabolic Parameters of Antipsychotic Child Treatment (IMPACT)$448,101
R01 · FY2009 · MH · contact PI
Treatment of Early Age Mania Study$539,243
U01 · FY2008 · MH · contact PI
1/3-Improving Metabolic Parameters of Antipsychotic Child Treatment (IMPACT)$479,615
R01 · FY2008 · MH · contact PI
Research Training in Child Psychopathology & Treatment$154,536
T32 · FY2008 · MH · contact PI
Follow-up of the PATS Sample$100,324
U01 · FY2008 · MH · contact PI
Research Training in Child Psychopathology & Treatment$168,460
T32 · FY2007 · MH · contact PI
Follow-up of the PATS Sample$101,525
U01 · FY2007 · MH · contact PI
TASA$1,688
M01 · FY2007 · RR · contact PI
Research Training in Child Psychopathology & Treatment$163,457
T32 · FY2006 · MH · contact PI
Follow-up of the PATS Sample$104,631
U01 · FY2006 · MH · contact PI
Research Training in Child Psychopathology &Treatment$115,187
T32 · FY2005 · MH
Follow-up of the PATS Sample$103,450
U01 · FY2005 · MH
Research Training in Child Psychopathology &Treatment$152,853
T32 · FY2004 · MH
Follow-up of the PATS Sample$103,517
U01 · FY2004 · MH
Methylphenidate Efficacy and Safety$627
M01 · FY2004 · RR
RESEARCH TRAINING IN CHILD PSYCHOPATHOLOGY &TREATMENT$178,870
T32 · FY2003 · MH
METHYLPHENIDATE EFFICACY AND SAFETY IN ADHD PRESCHOOLERS$43,915
U01 · FY2003 · MH
RESEARCH TRAINING IN CHILD PSYCHOPATHOLOGY &TREATMENT$164,645
T32 · FY2002 · MH
38 WEEK, MULTICENTER STUDY WITH OBSESSIVE COMPULSIVE DISORDER$0
M01 · FY2002 · RR
COMPARISON OF VENLAFAXINE EXTENDED RELEASE W/ PLACEBO$0
M01 · FY2002 · RR
FLUVOXAMINE TREATMENT OF ANXIETY DISORDERS IN CHILDREN AND ADOLESCENTS$0
M01 · FY2002 · RR
METHYLPHENIDATE EFFICACY AND SAFETY IN ADHD PRESCHOOLERS$460,211
U01 · FY2001 · MH
RESEARCH TRAINING IN CHILD PSYCHOPATHOLOGY &TREATMENT$174,286
T32 · FY2001 · MH
COMPARISON OF VENLAFAXINE EXTENDED RELEASE W/ PLACEBO$0
M01 · FY2001 · RR
FLUVOXAMINE TREATMENT OF ANXIETY DISORDERS IN CHILDREN AND ADOLESCENTS$0
M01 · FY2001 · RR
38 WEEK, MULTICENTER STUDY WITH OBSESSIVE COMPULSIVE DISORDER$0
M01 · FY2001 · RR
METHYLPHENIDATE EFFICACY AND SAFETY IN ADHD PRESCHOOLERS$442,649
U01 · FY2000 · MH
RESEARCH UNITS ON PEDIATRIC PSYCHOPHARMACOLOGY$330,391
N01 · FY2000 · MH
RESEARCH TRAINING IN CHILD PSYCHOPATHOLOGY &TREATMENT$187,667
T32 · FY2000 · MH
RESEARCH TRAINING IN CHILD PSYCHOPATHOLOGY &TREATMENT$3,383
T32 · FY2000 · MH
RESEARCH UNITS ON PEDIATRIC PSYCHOPHARMACOLOGY$0
N01 · FY2000 · MH
FLUVOXAMINE TREATMENT OF ANXIETY DISORDERS IN CHILDREN AND ADOLESCENTS$0
M01 · FY2000 · RR
COMPARISON OF VENLAFAXINE EXTENDED RELEASE W/ PLACEBO$0
M01 · FY2000 · RR
38 WEEK, MULTICENTER STUDY WITH OBSESSIVE COMPULSIVE DISORDER$0
M01 · FY2000 · RR